ICU Medical recalled the lot of Lactated Ringer’s Injection, a drug meant for intravenous replacement of extracellular fluid and electrolytes losses in humans and animals, May 8. The recall was issued to protect consumers against the adverse effects of iron oxide in the body, which include injection site inflammation and potentially fatal blood clots. ICU Medical said it has not received any reports of blood clots.
The affected product lot was produced in the U.S. in July 2019. ICU Medical said it was alerted to the problem after a customer complaint.
Read the full news release here.
More articles on pharmacy:
Drugmakers forced to reshape sales strategy amid pandemic
NIH to test remdesivir in combo with Eli Lilly arthritis drug
Regeneron says its COVID-19 antibody drug could be ready by fall
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
